Harvard Medical School

Right Drug, Wrong Patient: The AI Out to End Cancer's Costliest Mistake

A model published in Nature Medicine reads a tumour's gene activity to predict who will benefit from immunotherapy, and it works across many cancers and drugs, not just one.